Regulatory and Quality Solutions LLC Acquires Maetrics
Regulatory and Quality Solutions LLC (R&Q), a provider of regulatory and quality consulting services for medical devices, in vitro diagnostic devices (IVDs), and combination products, has announced that it has acquired Maetrics LLC.
“We are thrilled to be part of R&Q,” said Maetrics President, Steve Cottrell. “Together, we provide a truly unique consultancy offering to the life science industry. With our combined capabilities, clients know they are working with a partner that they can trust to deliver. The healthcare sector is so important to our everyday lives—now more than ever—and both R&Q and Maetrics are dedicated to continually supporting this mission with our effective regulatory and quality solutions.”
R&Q and Maetrics offer specialist consultancy services like to the medical device, diagnostics, and pharmaceutical industries.
Read more about those services in the full release, here.
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
May 2nd 2025Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly semaglutide improved liver histology, metabolic markers, and weight loss in patients with biopsy-confirmed metabolic dysfunction–associated steatohepatitis and stage 2 or 3 fibrosis.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
